KaydedilenlerDerginizi ekleyin

Dergiler / Cerrahpaşa Tıp Dergisi / 2006 / Cilt: 37 Sayı: 2

Cryptococcus Neoformans Kökenlerinin İn Vitro Fenol Oksidaz Etkinliğinin Belirlenmesi ve C. Neoformans'ın Candida Albicans Kolonilerinden Ayırdedilmesi İçin Pal Ağar ve Niger Seed Ağar Besiyerlerinin Karşılaştırılması

A.serda KANTARCIOĞLU
Ayhan YÜCEL
Valerio VİDOTTTO
Valerio VIDOTTO
Sayfa
37–40
Yayın Tarihi
2014-07-20
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

KANTARCIOĞLU, A., YÜCEL, A., VİDOTTTO, V., VIDOTTO, V. (2014). Cryptococcus Neoformans Kökenlerinin İn Vitro Fenol Oksidaz Etkinliğinin Belirlenmesi ve C. Neoformans'ın Candida Albicans Kolonilerinden Ayırdedilmesi İçin Pal Ağar ve Niger Seed Ağar Besiyerlerinin Karşılaştırılması. Cerrahpaşa Tıp Dergisi, Cilt: 37 Sayı: 2, 37–40. https://ajindex.com/articles/984025

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Dromer F, Mathoulin S, DupontB, l.aporteA. Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993), French Cryptococcosis Study Group. Clin Infect Dis 1996; 23: 82-90
  2. PerfectJ, Casadeval A. Cryptococcosis. Infect Dis Clin N Am 2002; 16: 837-874
  3. Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, Tracie G, Sattah M, Ponce de Leon G, Baughman W, Hajjeh RA. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 2003; 36: 789-794
  4. Viviani MA, Swinne D, Kouzmanov A, Dromer F, lintelnot K, Lemmer K, Velegraki A, Radlca N, Polacheck I, Antinori S, Cogliati M, Esposto C, Nowiclca J, Velho R, Vasilyeva N, Colom Valiente F, Petrini B, Polak AM, Schar G, Hoepelman H, Johnson E. Survey of cryptocoocosis in Europe: the ECMM Working Group report. Abstracts of 6th ECMM Congress, Barcelona, 9-11 November, 2000
  5. Viviani M. Epidemiological survey of cryptococcosis in Europe. Mycology Newsletter, February 2003: 6-7
  6. Van Elden U, Walenkamp AM, LipovskY MM, Reiss P, Meis JF, DE Marie S, DankertJ, Hoepelman AL. Declining number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy. AIDS 2000; 14: 2787-2788
  7. Tintelnot K, Schar G, Polak A. Epidemiological data of cryptoc:occosis in Austria, Germany and Swizerland: part of ECMM survey in Europe. Mycoses 2001; 44: 345-350
  8. Kantarcioglu S, Yucel A. Epidemiology of human cryptococcosis in Turkey in 1953-2003. In: Trends in Medical Myrology. Bologna, Monduzzi Editore, 2003: 59-66
  9. AbergJA, MundyLM, PowderlyWG. Pulmonarycryptococcosis in patients without HIV infection. Chest 1999; 115: 734-740
  10. NunezM, PeacockJE, Chin R. Pulmonarycryptococcosis in the immunocompetent host. Chest 2000; 118: 527-534
  11. Staib F, Seibold M, Antweiler E, Frolich B, Weber S, Blisse A. The brown color effect (BCE) of Cryptococcus neoformans in the diagnosis, control and epidemiology of C. neoformans infections in AIDS patients. Zentbl Bakteriol Microbial Hyg 1987; 266: 167-177
  12. Pal M, Onda C, Hasegawa A. Isolation of saprophytic Cryptococcus neoformans. Jpn J Vet. Sci 1990; 52: 1171-1174
  13. Pal M. Pulmonary mycosis in a pigeon handler due to Cryptococcus neoformans var. neoformans. 2nd International Conference on Cryptococcus and cryptococcosis. Milan (Italy), 1993. Abstracts, pp. 4-5, p. 119
  14. Yucel A, Kantarc1oglu AS. Dogadan ay1rd1g1m1z dort